InvestorsHub Logo

sstyles

05/02/21 1:05 AM

#338047 RE: Pharmacydude #338045

Great now all we need is a new management team to convey any positive news to the market.

It works ain’t gonna cut it. Smh.

MNBioMike

05/02/21 9:26 AM

#338065 RE: Pharmacydude #338045

Pdude: thx for the thorough response. I agree that V will likely show to be an effective treatment. I still don’t understand zero interest from the Street in this area though...they have access to all of the same data and no one cares. There were 100 or so people on the Argentina webcast.....probably 90 retail AMRN shareholders, lol.

Also, unpopular opinion, but I’m not impressed at the speed that these studies were established and conducted. Don’t get me wrong, I don’t think Amarin separately would have done them quicker, but getting first results 15 months after the pandemic started isn’t exactly agility in my book. Again, they have one drug. Especially for an illness that lasts only a few weeks. We should have been hearing results last fall.

dukesking

05/02/21 11:59 AM

#338078 RE: Pharmacydude #338045

PDUDE, Thanks for sharing your research and knowledge with us. It was very well presented, educational, encouraging and very informative. Much appreciated.

rafunrafun

05/02/21 12:54 PM

#338081 RE: Pharmacydude #338045

The V / COVID situation today reminds me of the V / CVD situation a few months before the REDUCE-IT topline results. Not many gave it a chance of success but those who have really studied it (JL and others), thought differently.